312 related articles for article (PubMed ID: 17114494)
41. Migrating human neutrophils exhibit dynamic spatiotemporal variation in membrane lipid organization.
Sitrin RG; Sassanella TM; Landers JJ; Petty HR
Am J Respir Cell Mol Biol; 2010 Oct; 43(4):498-506. PubMed ID: 19933376
[TBL] [Abstract][Full Text] [Related]
42. Dietary linoleate supplementation modulates formyl-peptide receptor expression and functional responses of rat neutrophils.
Gyllenhammar H; Hafström I; Borgeat P; Ringertz B; Becker W; Svensson J; Palmblad J
J Lab Clin Med; 1990 Apr; 115(4):487-96. PubMed ID: 2157784
[TBL] [Abstract][Full Text] [Related]
43. Synergism between chemotactic peptide and platelet-activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
Tanizawa H; Tai HH
Biochem Pharmacol; 1989 Aug; 38(15):2559-63. PubMed ID: 2547385
[TBL] [Abstract][Full Text] [Related]
44. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents.
Rosenthal MD; Franson RC
J Cell Physiol; 1994 Sep; 160(3):522-30. PubMed ID: 8077290
[TBL] [Abstract][Full Text] [Related]
45. Zymosan-induced leukotriene B4 generation by human neutrophils is augmented by rhTNF-alpha but not chemotactic peptide.
Petersen M; Steadman R; Hallett MB; Matthews N; Williams JD
Immunology; 1990 May; 70(1):75-81. PubMed ID: 2162325
[TBL] [Abstract][Full Text] [Related]
46. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
Rollins TE; Zanolari B; Springer MS; Guindon Y; Zamboni R; Lau CK; Rokach J
Prostaglandins; 1983 Feb; 25(2):281-9. PubMed ID: 6304818
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils.
Surette ME; Dallaire N; Jean N; Picard S; Borgeat P
FASEB J; 1998 Nov; 12(14):1521-31. PubMed ID: 9806761
[TBL] [Abstract][Full Text] [Related]
48. Phospholipid flip-flop and phospholipid scramblase 1 (PLSCR1) co-localize to uropod rafts in formylated Met-Leu-Phe-stimulated neutrophils.
Frasch SC; Henson PM; Nagaosa K; Fessler MB; Borregaard N; Bratton DL
J Biol Chem; 2004 Apr; 279(17):17625-33. PubMed ID: 14766753
[TBL] [Abstract][Full Text] [Related]
49. Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells.
Eun JC; Moore EE; Banerjee A; Kelher MR; Khan SY; Elzi DJ; McLaughlin NJ; Silliman CC
Shock; 2011 Mar; 35(3):240-4. PubMed ID: 20926984
[TBL] [Abstract][Full Text] [Related]
50. Mechanism of action of leukotriene B4: intracellular calcium redistribution in rabbit neutrophils.
Naccache PH; Molski TF; Borgeat P; Sha'afi RI
J Cell Physiol; 1984 Jan; 118(1):13-8. PubMed ID: 6317702
[TBL] [Abstract][Full Text] [Related]
51. Formyl peptide-receptor like-1 requires lipid raft and extracellular signal-regulated protein kinase to activate inhibitor-kappa B kinase in human U87 astrocytoma cells.
Kam AY; Liu AM; Wong YH
J Neurochem; 2007 Nov; 103(4):1553-66. PubMed ID: 17727628
[TBL] [Abstract][Full Text] [Related]
52. Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists.
Palmantier R; Borgeat P
Br J Pharmacol; 1991 Aug; 103(4):1909-16. PubMed ID: 1655146
[TBL] [Abstract][Full Text] [Related]
53. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
Palmer RM; Salmon JA
Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653
[TBL] [Abstract][Full Text] [Related]
54. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.
Riesselman M; Miettinen HM; Gripentrog JM; Lord CI; Mumey B; Dratz EA; Stie J; Taylor RM; Jesaitis AJ
J Immunol; 2007 Aug; 179(4):2520-31. PubMed ID: 17675514
[TBL] [Abstract][Full Text] [Related]
55. Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes.
Kreisle RA; Parker CW
J Exp Med; 1983 Feb; 157(2):628-41. PubMed ID: 6296265
[TBL] [Abstract][Full Text] [Related]
56. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
57. 13-HODE inhibits the intracellular calcium increase of activated human polymorphonuclear cells.
van de Velde MJ; Engels F; Henricks PA; Nijkamp FP
J Leukoc Biol; 1994 Aug; 56(2):200-2. PubMed ID: 8071595
[TBL] [Abstract][Full Text] [Related]
58. Leukotriene synthesis in calcium-depleted human neutrophils: arachidonic acid release correlates with calcium influx.
Krump E; Pouliot M; Naccache PH; Borgeat P
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):681-8. PubMed ID: 7654211
[TBL] [Abstract][Full Text] [Related]
59. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
Denis D; Riendeau D
Eur J Pharmacol; 1999 Feb; 367(2-3):343-50. PubMed ID: 10079010
[TBL] [Abstract][Full Text] [Related]
60. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils.
Chen LW; Lin MW; Hsu CM
J Biomed Sci; 2005; 12(2):311-9. PubMed ID: 15917990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
